期刊文献+

皮肤创面愈合过程中上皮间质化机制的研究 被引量:5

Research of the mechanism of epithelial mesenchymal transition during skin wound healing
下载PDF
导出
摘要 目的:探讨β2肾上腺素受体(β2-AR)在皮肤创伤修复上皮间质化(EMT)过程中的作用机制及意义。方法:采用免疫印迹法(Western blot)、逆转录-聚合酶链式反应(RT-PCR)、免疫荧光技术等实验方法,体外观察β2-AR激动剂(ISO)和抑制剂(ICI)对上皮细胞间质化标志物(α-平滑肌肌动蛋白、波形蛋白、snail)表达的影响及创面皮肤上皮化标志物(E-钙黏附素)表达的变化。结果:β2-AR可通过介导皮肤创面愈合的EMT过程,促进表皮细胞向间质表型转化,且运动和迁移能力在该过程中不断增强。结论:β2-AR是皮肤上皮间质化的关键分子,其介导的EMT过程是皮肤创面愈合的生物学基础。 Objective: To explore the mechanism and significance of β2-adrenergic receptor (β2-AR) in the procedure of epithelial mesenchymal transition (EMT) during wound healing and tissue regeneration. Methods: The influence of β2-AR agonist (ISO) and inhibitor (ICI) on the expression of markers of mesenchymal transition (a-smooth muscle actin, vimentin, snail) or marker of epithelization (E-cadherin) in epidermis cells during wound healing and tissue regeneration was observed using western blot, reverse transcription polymerase chain reaction (RT-PCR) and immunofluorescence. Results: The epithelial cells gained mesenchymal phenotypic feature, and got stronger ability in movement and migration. β2-AR was a critical molecule which mediated EMT process. Conelusions: β2-AR is a key molecule in the procedure of EMT, and β2-AR mediated EMT is a biological basis of skin wound healing and matrix remodeling.
出处 《感染.炎症.修复》 2016年第3期136-139,F0003,共5页 Infection Inflammation Repair
基金 国家自然科学基金资助项目(30901564 81101883 81245185 81372067 81121004 81230041) 国家973计划项目(2012CB518105)
关键词 创面愈合 上皮间质化 表皮细胞 Wound healing Epithelial mesenchymal transition Epithelial cells
  • 相关文献

参考文献3

二级参考文献33

  • 1方勇,程瑞杰,王莹,徐英华,包士三.糖尿病小鼠创面愈合过程中炎症细胞和GM-CSF表达[J].上海交通大学学报(医学版),2007,27(2):174-177. 被引量:15
  • 2程瑞杰,方勇,俞为荣,王莹.粒细胞巨噬细胞集落刺激因子对糖尿病小鼠创面愈合的作用[J].上海交通大学学报(医学版),2007,27(4):415-418. 被引量:19
  • 3Kaufman T,Kalderon D,Ullmann Y,et al.Aloe vera del hindered wound healing of exerpimental second-degree burns:a quantitative controlled study.J Burn Care Rehabil,1988,9(2):156-159.
  • 4Mann A,Breuhahn K,Schirmacher P,et al.Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing:stimulation of keratinocyte proliferation,granulation tissue formation,and vascularization.J Invest Dermatol,2001,117(6):1382-1390.
  • 5Cianfarani F,Tommasi R,Failla CM,et al.Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed.Br J Dermatol,2006,154(1):34-41.
  • 6Fang Y,Gong SJ,Xu YH,et al.Impaired cutaneous wound healing in granulocyte-macrophage colony-stimulating factor knockout mice.Br J Dermatol,2007,157(3):458-465.
  • 7Meier K,Nanney LB.Emerging new drugs for wound repair.Expert Opin Emerg Drugs,2006,11(1):23-37.
  • 8Groves RW,Schmidt-Lucke JA.Recombinant human GM-CSF in the treatment of poorly healing wounds.Advances Skin Wound Care,2000,13(3 Pt 1):107-112.
  • 9Mann A,Niekisch K,Schirmacher P.Granulocyte-macrophage colony-stimulating factor is essential for normal wound healing.J Invest Dermatol Symposi Proceed,2006,11(1):87-92.
  • 10Zhang LP,Chen J,Han CM.A multicenter clinical trial of recombinant human GM-CSF hydrogel for the treatment of deep second-degree burns.Wound Rep Reg,2009,17(5):685-689.

共引文献47

同被引文献36

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部